These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 36593970)

  • 1. Engineered biomembrane-derived nanoparticles for nanoscale theranostics.
    Wu Z; Zhang H; Yan J; Wei Y; Su J
    Theranostics; 2023; 13(1):20-39. PubMed ID: 36593970
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Engineering carrier nanoparticles with biomimetic moieties for improved intracellular targeted delivery of mRNA therapeutics and vaccines.
    Puccetti M; Pariano M; Schoubben A; Ricci M; Giovagnoli S
    J Pharm Pharmacol; 2024 Jun; 76(6):592-605. PubMed ID: 38092697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stem cell membrane, stem cell-derived exosomes and hybrid stem cell camouflaged nanoparticles: A promising biomimetic nanoplatforms for cancer theranostics.
    Khosravi N; Pishavar E; Baradaran B; Oroojalian F; Mokhtarzadeh A
    J Control Release; 2022 Aug; 348():706-722. PubMed ID: 35732250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hybrid nanostructures for neurodegenerative disease theranostics: the art in the combination of biomembrane and non-biomembrane nanostructures.
    Gao C; Xiong R; Zhang ZY; Peng H; Gu YK; Xu W; Yang WT; Liu Y; Gao J; Yin Y
    Transl Neurodegener; 2024 Aug; 13(1):43. PubMed ID: 39192378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The potential of biomimetic nanoparticles for tumor-targeted drug delivery.
    Li B; Wang F; Gui L; He Q; Yao Y; Chen H
    Nanomedicine (Lond); 2018 Aug; 13(16):2099-2118. PubMed ID: 30226404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surface Engineering of Nanoparticles toward Cancer Theranostics.
    Huang P; Wang C; Deng H; Zhou Y; Chen X
    Acc Chem Res; 2023 Jul; 56(13):1766-1779. PubMed ID: 37314368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biomembrane camouflaged nanoparticles: A paradigm shifts in targeted drug delivery system.
    Qureshi SA; Rafiya K; Awasthi S; Jain A; Nadaf A; Hasan N; Kesharwani P; Ahmad FJ
    Colloids Surf B Biointerfaces; 2024 Jun; 238():113893. PubMed ID: 38631282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. "Nanodecoys" - Future of drug delivery by encapsulating nanoparticles in natural cell membranes.
    Imran M; Jha LA; Hasan N; Shrestha J; Pangeni R; Parvez N; Mohammed Y; Jha SK; Paudel KR
    Int J Pharm; 2022 Jun; 621():121790. PubMed ID: 35504432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Construction of magnetic drug delivery system and its potential application in tumor theranostics.
    Jiang M; Liu Q; Zhang Y; Wang H; Zhang J; Chen M; Yue Z; Wang Z; Wei X; Shi S; Wang M; Hou Y; Wang Z; Sheng F; Tian N; Wang Y
    Biomed Pharmacother; 2022 Oct; 154():113545. PubMed ID: 36007274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biomimetic Targeted Theranostic Nanoparticles for Breast Cancer Treatment.
    Marshall SK; Angsantikul P; Pang Z; Nasongkla N; Hussen RSD; Thamphiwatana SD
    Molecules; 2022 Oct; 27(19):. PubMed ID: 36235009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Membrane engineering of cell membrane biomimetic nanoparticles for nanoscale therapeutics.
    Zhang M; Cheng S; Jin Y; Zhang N; Wang Y
    Clin Transl Med; 2021 Feb; 11(2):e292. PubMed ID: 33635002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hybrid cell membrane-coated nanoparticles: A multifunctional biomimetic platform for cancer diagnosis and therapy.
    Chen HY; Deng J; Wang Y; Wu CQ; Li X; Dai HW
    Acta Biomater; 2020 Aug; 112():1-13. PubMed ID: 32470527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent trends in cell membrane-cloaked nanoparticles for therapeutic applications.
    Choi B; Park W; Park SB; Rhim WK; Han DK
    Methods; 2020 May; 177():2-14. PubMed ID: 31874237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelets for cancer treatment and drug delivery.
    Xiao G; Zhang Z; Chen Q; Wu T; Shi W; Gan L; Liu X; Huang Y; Lv M; Zhao Y; Wu P; Zhong L; He J
    Clin Transl Oncol; 2022 Jul; 24(7):1231-1237. PubMed ID: 35218523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biomembrane-Derived Nanoparticles in Alzheimer's Disease Therapy: A Comprehensive Review of Synthetic Lipid Nanoparticles and Natural Cell-Derived Vesicles.
    Gao C; Liu Y; Zhang TL; Luo Y; Gao J; Chu JJ; Gong BF; Chen XH; Yin T; Zhang J; Yin Y
    Int J Nanomedicine; 2023; 18():7441-7468. PubMed ID: 38090364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell membrane coated nanoparticles: next-generation therapeutics.
    Narain A; Asawa S; Chhabria V; Patil-Sen Y
    Nanomedicine (Lond); 2017 Nov; 12(21):2677-2692. PubMed ID: 28965474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel nanoparticulate drug delivery systems.
    Friedrich RP; Pöttler M; Cicha I; Lyer S; Janko C; Alexiou C
    Nanomedicine (Lond); 2016 Mar; 11(6):573-6. PubMed ID: 26911384
    [No Abstract]   [Full Text] [Related]  

  • 18. Emerging platelet-based drug delivery systems.
    Fang M; Liu R; Fang Y; Zhang D; Kong B
    Biomed Pharmacother; 2024 Aug; 177():117131. PubMed ID: 39013224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Engineering Platelet Membrane Imitating Nanoparticles for Targeted Therapeutic Delivery.
    Adhalrao SB; Jadhav KR; Patil PL; Kadam VJ; Nirmal MK
    Curr Pharm Biotechnol; 2024; 25(10):1230-1244. PubMed ID: 37539932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biomembrane-based nanostructures for cancer targeting and therapy: From synthetic liposomes to natural biomembranes and membrane-vesicles.
    Wang J; Zhu M; Nie G
    Adv Drug Deliv Rev; 2021 Nov; 178():113974. PubMed ID: 34530015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.